Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL.

Saved in:

Bibliographic Details
Title:	Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL.
Authors:	Middleton O; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Cosimo E; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Dobbin E; Department of Haematology, Western General Hospital, Edinburgh, UK., McCaig AM; 1] Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK [2] Department of Haematology, Royal Alexandra Hospital, Paisley, UK., Clarke C; GlaxoSmithKline UK Ltd, Stockley Park West, Uxbridge, Middlesex, UK., Brant AM; GlaxoSmithKline UK Ltd, Stockley Park West, Uxbridge, Middlesex, UK., Leach MT; Department of Haematology, West of Scotland Cancer Centre, Gartnavel General Hospital, Glasgow, UK., Michie AM; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Wheadon H; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Source:	Leukemia [Leukemia] 2015 Jan; Vol. 29 (1), pp. 107-14. Date of Electronic Publication: 2014 May 02.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1476-5551
DOI:	10.1038/leu.2014.146